26 phenotypes from 5 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Skiltm1.1Kluo/Skiltm1.1Kluo B6.129P2-Skiltm1.1Kluo	decreased fibroblast proliferation	J:154718
	decreased incidence of tumors by chemical induction	J:154718
	decreased tumor growth/size	J:154718
	early cellular replicative senescence	J:154718
	prenatal lethality, incomplete penetrance	J:154718
Skiltm1b(EUCOMM)Hmgu/Skiltm1b(EUCOMM)Hmgu C57BL/6N-Skiltm1b(EUCOMM)Hmgu/BayMmucd	increased heart left ventricle size	J:211773
Skiltm1Sis/Skil+ involves: C57BL/6 * CBA	cachexia	J:62174
	increased B cell derived lymphoma incidence	J:62174
	increased incidence of tumors by chemical induction	J:62174
	increased susceptibility to xenobiotic induced morbidity/mortality	J:62174
	increased T cell derived lymphoma incidence	J:62174
Skiltm1Sis/Skiltm1Sis involves: C57BL/6 * CBA	embryonic lethality before implantation, complete penetrance	J:62174
	failure of zygotic cell division	J:62174
Skiltm1Spw/Skiltm1Spw either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immune system cell morphology	J:84554
	abnormal immune system organ morphology	J:84554
	decreased T cell proliferation	J:84554
	enlarged spleen	J:84554
	normal neoplasm	J:84554
Skiltm2Spw/Skiltm2Spw either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased T cell proliferation	J:84554
	normal immune system phenotype	J:84554
	normal neoplasm	J:84554
Skiltm2Spw/Skiltm2Spw involves: 129S1/Sv * 129X1/SvJ	abnormal mammary gland alveolus morphology	J:222343
	abnormal mammary gland epithelium morphology	J:222343
	abnormal mammary gland growth during lactation	J:222343
	abnormal mammary gland luminal epithelium morphology	J:222343
	abnormal mammary gland physiology	J:222343
	hypolactation	J:222343
	impaired mammary gland growth during pregnancy	J:222343